Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report.


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
31 07 2020
Historique:
received: 23 04 2020
accepted: 01 07 2020
entrez: 15 8 2020
pubmed: 15 8 2020
medline: 26 8 2020
Statut: epublish

Résumé

Coronavirus disease 19 (COVID-19) is the greatest pandemic in modern history. Laboratory test alterations have been described in COVID-19 patients, but differences with other pneumonias have been poorly investigated to date, especially in Caucasian populations. The aim of this study was to investigate differences and prognostic potential of routine blood tests in a series of Italian patients with COVID-19 and non-COVID-19 interstitial pneumonia. Clinical data and routine laboratory tests of a consecutive series of 30 COVID-19 patients and 30 age and sex matched patients with non COVID-19 interstitial pneumonia have been retrospectively collected. Differences in laboratory tests between patients with COVID-19 and non COVID-19 pneumonias have been investigated, as well as differences between COVID-19 survivors and non survivors. COVID-19 patients had lower white blood cells, monocytes, neutrophils, and higher platelet counts. In addition, COVID-19 patients showed higher mean platelet volume, lower C reactive protein concentrations, and higher De Ritis ratio. Combined blood cell indexes of systemic inflammation were significantly lower in COVID-19 patients. In further analysis of the COVID-19 group, the neutrophil count, neutrophil to lymphocyte ratio (NLR), derived NLR, systemic inflammation response index and De Ritis ratio, were significantly higher in non survivors than in survivors, while the number of platelets was significantly lower in non survivors. Our study showed several alterations in blood cell populations and indexes in patients with COVID-19 pneumonia in comparison with patients with non COVID-19 pneumonia. Some of these indexes showed promising prognostic abilities. Further studies are necessary to confirm these results.

Identifiants

pubmed: 32794454
doi: 10.3855/jidc.12879
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

685-690

Informations de copyright

Copyright (c) 2020 Panagiotis Paliogiannis, Angelo Zinellu, Valentina Scano, Giulia Mulas, Giacomo De Riu, Rosa M Pascale, Luigi B Arru, Ciriaco Carru, Pietro Pirina, Arduino A Mangoni, Alessandro G Fois.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Panagiotis Paliogiannis (P)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy. ppaliogiannis@uniss.it.

Angelo Zinellu (A)

Department of Biomedical Sciences, University of Sassari, Sassari, Italy. azinellu@uniss.it.

Valentina Scano (V)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy. valescano93@gmail.com.

Giulia Mulas (G)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy. giulia_mulas@hotmail.it.

Giacomo De Riu (G)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy. gderiu@uniss.it.

Rosa M Pascale (RM)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy. patsper@uniss.it.

Luigi B Arru (LB)

Operative Unit of Hematology, Center for Stem Cell Transplantation, San Francesco Hospital, Nuoro, Italy.

Ciriaco Carru (C)

Department of Biomedical Sciences, University of Sassari, Sassari, Italy. carru@uniss.it.

Pietro Pirina (P)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy. pirina@uniss.it.

Arduino A Mangoni (AA)

Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, Australia. arduino.mangoni@flinders.edu.au.

Alessandro G Fois (AG)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy. agfois@uniss.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH